Abstract
Over the last decade, with increasing use of aggressive chemotherapy and bone marrow transplantation in the treatment of cancer, fungi have emerged as a major pathogen. The prognosis of established systemic fungal infections remains poor, but newer antifungal drugs such as fluconazole are changing the outlook of therapy and prophylaxis considerably.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 180-184 |
| Number of pages | 5 |
| Journal | Indian journal of cancer |
| Volume | 31 |
| Issue number | 3 |
| State | Published - Sep 1994 |
ASJC Scopus subject areas
- Oncology
